Renhe Pharmacy Co., Ltd.

符号: 000650.SZ

SHZ

6.57

CNY

今天的市场价格

13.8854
市盈率
3.1936
PEG比率
9.20B
MRK市值
0.03%
DIV收益率

Renhe Pharmacy Co., Ltd. (000650-SZ) 财务报表

Q: 什么是 Renhe Pharmacy Co., Ltd. (000650.SZ) 总资产是多少？

Renhe Pharmacy Co., Ltd. (000650.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Renhe Pharmacy Co., Ltd. (000650.SZ). 的默认数据。公司收入显示 1605.221 M 的平均值，即 0.763 % 增长率。整个期间的平均毛利润为 639.845 M，即 0.964 %. 平均毛利率为 0.295 %. 公司去年的净收入增长率为 -0.136 %，等于 -0.127 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Renhe Pharmacy Co., Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.105. 在流动资产领域，000650.SZ 的报告货币为4580.859. 这些资产中的很大一部分，即 3242.35 是现金和短期投资。与去年的数据相比，该部分的变化率为0.212%. 公司的长期投资虽然不是其重点，但以报告货币计算的119.532（如果有的话）为119.532。这表明与上一报告期相比，55.055% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 5.793. 这一数字表明，0.938% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 5740.789. 这方面的年同比变化率为 0.086%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为582.458，存货估值为 457.74，商誉估值为 578.24（如有. 无形资产总额（如果有）按 602.2 估值.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995	1993
balance-sheet.row.cash-and-short-term-investments	12028.24	3242.3	2676	2168.8	2224.4	1764.1	1361.5	1051.9	816	640.8	544.4	455.2	266.3	289.3	358.2	129.1	79	47.7	3.7	42.6	105.5	151.9	129.1	117.7	142.4	53.7	36.9	71.6	1.1	3.7	2.9
balance-sheet.row.short-term-investments	5637.48	416.9	315.6	460.9	805.1	7.9	10	8.8	8.2	6.7	5.2	5.5	8.3	9.2	7.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	3217.73	582.5	647.3	501.6	563.2	597.8	549	485.9	568.9	477.1	463.3	458.3	686.6	632	253.6	177.5	95.5	57.9	117.7	157.8	172.6	211	207.1	111.9	33.1	91.3	89.7	44.6	9.1	3.6	3
balance-sheet.row.inventory	1806.76	457.7	601.4	451.7	522.9	533.1	455.9	457	369.1	303.4	251.7	201	160.3	138.8	38.7	27.8	17.8	62	40.8	86.4	84.4	68.8	63	78.9	37.3	41.2	1.3	13.9	26.9	23.4	20
balance-sheet.row.other-current-assets	1566.18	298.3	131	711.4	9.2	10.5	17.9	9.7	3	3.6	7.6	9.7	-8	-5.7	30.9	-35.1	-10.9	-27.3	-1.1	-2.5	-1.5	-1.6	-31.7	4.8	5.9	4.7	6	11.7	2.9	10.8	7.8
balance-sheet.row.total-current-assets	18618.91	4580.9	4055.7	3833.5	3319.7	2905.4	2384.3	2004.6	1757	1424.8	1267.1	1124.1	1105.3	1054.4	681.4	299.3	181.4	140.3	161.1	284.3	361	430.1	367.6	313.2	218.8	190.9	133.8	141.8	40	41.5	33.7
balance-sheet.row.property-plant-equipment-net	4986.1	1240.7	1111.6	744	629.8	631.8	679.7	721.6	649.3	559	527.4	452.3	222.5	155.7	123.9	24.5	25	24.3	292.7	314.4	318.4	329.5	344.3	338.2	257	168.6	143.6	127.8	130.8	131.3	96
balance-sheet.row.goodwill	2312.95	578.2	606.1	102.2	102.2	377.9	420	437.8	131.1	102.2	102.2	95.7	9.9	9.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2462.49	602.2	650.6	664.5	666.2	661.6	663.4	682	375.5	398.6	422.3	418.1	256.1	253.8	247.1	113.7	101.5	107	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	4775.44	1180.4	1256.8	766.7	768.4	1039.4	1083.4	1119.8	506.5	500.8	524.5	513.8	266	263.7	247.1	113.7	101.5	107	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	-3458.37	119.5	77.1	439.1	-599.8	5.1	-9.9	-8.5	-8	6.2	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	71.29	17.7	6.6	5.5	6.9	7.2	5.1	7.3	4.4	7.3	6.1	2.7	0.7	0.2	0.7	0.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	5902.29	492.4	400.2	516.3	859.6	27.7	24.7	20.1	247.1	99	2.6	2	8.3	4.2	7.8	0	0	0.2	2.2	2.1	0	0	0	0.2	0.4	0.6	0.8	0.2	0	0	0
balance-sheet.row.total-non-current-assets	12276.76	3050.8	2852.2	2471.6	1664.7	1711.3	1783.1	1860.3	1399.3	1172.3	1061.7	970.8	497.5	423.8	379.5	138.5	127.1	131.4	294.9	316.5	318.4	329.6	344.4	338.4	257.5	169.2	144.4	128	130.8	131.3	96
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	30895.67	7631.6	6907.9	6305.1	4984.4	4616.7	4167.4	3864.9	3156.3	2597.1	2328.7	2094.9	1602.8	1478.2	1060.9	437.8	308.5	271.7	456	600.7	679.4	759.7	711.9	651.6	476.2	360.1	278.2	269.7	170.8	172.7	129.7
balance-sheet.row.account-payables	1296.75	199.6	176.1	147.2	142.2	213.7	230.1	236.8	229.7	180.6	152.2	149.3	202.6	278.9	44.4	19.7	40.3	10.8	62.2	92.6	60.2	72.2	47.1	46.3	13.6	0.3	0.2	0.1	2.2	0	0
balance-sheet.row.short-term-debt	16.88	6.7	2.8	60.1	-74.1	0	0	0	0	0	0	0	20	20	0	0	0	0	312.3	316	217	156.3	104.3	24.3	14	31	25	25	23	0	0
balance-sheet.row.tax-payables	863.94	279.9	273.8	126.6	172	173.2	148.6	136.5	157.1	101.1	49.9	68.5	50.4	52.2	20.7	25.8	7.4	30.1	13.1	2.6	2.1	6.6	4.8	5.2	6.7	2.8	3.6	5.9	2.4	0	0
balance-sheet.row.long-term-debt-total	23.17	5.8	3.6	2.7	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	142.3	169.3	205.3	205.3	169.4	86.8	86.8	91.3	90.7	0	0
Deferred Revenue Non Current	154.4	38.8	8.3	9.4	8.8	10.1	11.4	13.6	15	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	2.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1205.38	603.6	51.5	42.1	481	477.3	452.9	409.3	308.6	235	218.5	214.5	151.4	189	159.3	112.5	32.7	66.3	3.8	2.2	4.3	4.1	3.9	6.7	2.7	0.3	0.4	1.4	0.2	37.3	30
balance-sheet.row.total-non-current-liabilities	180.38	45.3	12.3	9.8	9.3	10.6	11.9	14.3	17.2	19.4	19.2	19	18.5	0	0	0	0	0	2.6	2.9	143.2	169.8	205.6	205.3	169.4	86.8	86.8	91.3	90.7	86.8	86.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	-18.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	23.17	5.8	3.6	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	4461.31	1209.9	981	694.5	632.5	701.7	694.9	660.4	555.4	435.1	389.9	382.8	460.7	566.1	203.7	132.2	73	77	409.1	431.7	441.2	420.9	380.4	306.3	214.7	126.3	118.8	126.7	119.5	124.1	116.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	5599.75	1399.9	1399.9	1399.9	1238.3	1238.3	1238.3	1238.3	1238.3	990.7	990.7	990.7	630.2	420.2	280.1	220.1	220.1	200.1	200.1	200.1	200.1	200.1	200.1	111.2	102.7	85.6	78	52	11	11	11
balance-sheet.row.retained-earnings	13087.09	3142	2742.7	2412.6	2021	1607	1255.5	1017.2	685.3	590.7	401.3	230.7	417.7	392.8	261.2	4.6	-69.3	-104.7	-242.8	-119.1	-50	50.6	43.5	80.3	67.3	43.7	19.7	5.7	0	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	4012.01	415.3	390.6	307.1	254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	783.55	783.6	754.1	953.3	292.3	546.2	514.7	496.3	465.4	451.5	434.5	399.4	69	61.1	315.1	80.9	84.7	99.3	89.6	88.1	88.1	88.1	88	153.9	91.5	104.4	61.8	85.3	40.3	37.7	1.9
balance-sheet.row.total-stockholders-equity	23482.4	5740.8	5287.2	5072.9	3805.6	3391.6	3008.5	2751.9	2389	2032.9	1826.4	1620.8	1116.9	874.1	856.4	305.6	235.4	194.7	46.9	169	238.2	338.7	331.6	345.3	261.5	233.8	159.4	143.1	51.3	48.7	12.9
balance-sheet.row.total-liabilities-and-stockholders-equity	30895.67	7631.6	6907.9	6305.1	4984.4	4616.7	4167.4	3864.9	3156.3	2597.1	2328.7	2094.9	1602.8	1478.2	1060.9	437.8	308.5	271.7	456	600.7	679.4	759.7	711.9	651.6	476.2	360.1	278.2	269.7	170.8	172.7	129.7
balance-sheet.row.minority-interest	2951.95	681	639.7	537.6	546.4	523.4	463.9	452.6	211.8	129.1	112.4	91.3	25.2	38	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	26434.35	6421.8	5926.9	5610.5	4352	3915	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	30895.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	2179.11	536.4	392.7	900	205.3	7.9	0.1	0.3	0.2	6.7	5.2	5.5	8.3	9.2	7.9	0	0	0.2	2.2	2.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	40.06	12.5	6.5	60.1	0	0	0	0	0	0	0	0	20	20	0	0	0	0	312.3	316	359.3	325.6	309.6	229.6	183.4	117.8	111.8	116.3	113.7	0	0
balance-sheet.row.net-debt	-6350.71	-2813	-2354	-1647.8	-1419.2	-1756.2	-1351.5	-1043.1	-807.8	-634	-539.2	-449.6	-238	-260	-350.3	-129.1	-79	-47.7	308.6	273.5	253.7	173.7	180.4	111.9	40.9	64.1	74.9	44.7	112.6	-3.7	-2.9

现金流量表

在 Renhe Pharmacy Co., Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 2.774 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 182.28. 公司的投资活动产生了现金使用净额，按报告货币计算达到-575166939.980. 与上一年相比， -2.802 发生了变化. 在同一时期，公司记录了 117.15, 0.29 和 -5.55，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-140.17 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -84.36，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	658.36	711.6	799.9	657.7	619.3	584.1	441.2	430.8	435.6	323.9	216	276.1	305.8	225.7	165.5	70.2	39.2	130.3	-129.9	-69.1	-100.5	8.8	-12.7	21.8	27.7	28.3
cash-flows.row.depreciation-and-amortization	118.85	117.2	86.6	83.9	96.3	91.8	87.2	80.3	74.1	69	64.2	56.2	29.4	26.8	20.6	8.6	8.3	20.8	22.3	27.4	27.1	26.9	23.5	18.6	12.8	11.5
cash-flows.row.deferred-income-tax	-254.17	-10.8	-0.8	1.1	-1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	17.32	17.3	10.4	-1.1	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	238.73	410.2	-86.3	194.5	-34.3	-147.8	-18.3	33.2	-56.2	-17	-81	-138.9	-178.6	-129.8	13.4	-16.2	-12.9	389.4	-30.1	4.4	-100.4	-21.5	-14.4	-85.2	16.3	-35.6
cash-flows.row.account-receivables	127.1	127.1	-62.5	54.2	-107.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	111.63	111.6	-124.4	69.8	-25	-81.3	0.8	-61.9	-56.8	-53.4	-50.5	-33	-21.6	-41	4.5	-9.3	43.5	49.5	45.9	-3.1	-15.7	-5.2	15.6	-41.4	3.4	-28.9
cash-flows.row.account-payables	0	182.3	101.3	68.9	99	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-10.8	-0.8	1.7	-1.3	-66.5	-19.1	95	0.6	36.4	-30.4	-105.9	-157	-88.8	8.9	-6.9	-56.4	339.9	-76.1	7.5	-84.7	-16.3	-30	-43.8	12.9	-6.6
cash-flows.row.other-non-cash-items	-80.5	24.6	-32.1	-64.9	12.7	41.4	-12.2	-22.2	-18.8	-10.6	14.1	-9.5	10.3	7.4	1.1	-0.4	0.8	-305.3	120.1	54.9	123.6	13.8	7.1	7.8	10.6	10.2
cash-flows.row.net-cash-provided-by-operating-activities	698.58	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-197.29	-221.1	-499.8	-218.2	-144.1	-70.1	-43.6	-59.9	-77.4	-137.5	-94.1	-242.1	-101.5	-28.6	-58.5	-12.1	-4.6	-38.2	-5.9	-23.6	-16.6	-7.2	-30.2	-93	-36.1	-13
cash-flows.row.acquisitions-net	1.26	15.8	-704.6	188.8	77.9	30	0.5	-153.2	-2.8	1.6	-22.9	-111.1	-51.9	-175.1	-622.7	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-6122.14	-8033	-10846.8	-11925	-11831.1	-8776.7	-6306.3	-7587.6	-7845.7	-6922.3	-5807.4	-2108.8	-40.9	-45.4	-78.4	0	0	-163.2	0	-2.1	0	0	-31	0	0	0
cash-flows.row.sales-maturities-of-investments	6052	7662.9	12347.9	10753.2	11034.2	8793.8	6326.5	7528.3	7884.5	6937.7	5814.1	2111.8	40.8	72.9	72.1	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-1.21	0.3	22.6	1.1	0.1	-0.5	-28.9	-1.2	-195.5	-38.8	-0.9	43.6	0.1	0.1	0.1	0.1	0.3	0	7.3	6.7	5.6	5.3	8.3	5.6	1.6	0
cash-flows.row.net-cash-used-for-investing-activites	-267.38	-575.2	319.3	-1200.1	-862.9	-23.5	-51.8	-273.6	-236.9	-159.3	-111.2	-306.6	-153.3	-176.2	-687.4	-12	-4.3	-201.4	1.4	-18.9	-11	-1.9	-52.9	-87.4	-34.5	-13
cash-flows.row.debt-repayment	0	-5.5	-60	-60	0	0	0	-0.7	0	0	0	-22.6	-20	-23.9	0	0	0	-46	-165.3	-180.2	-163.3	-74	-28.3	-105.8	-6	0
cash-flows.row.common-stock-issued	0	0	139.7	-0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	-199.6	-59.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-280.16	-140.2	-283.2	-169.6	-123.9	-124.6	-121.5	-0.1	-25.7	-99.1	-16.1	-40.6	-24.5	-84.7	0	0	0	0	-17.8	-20.3	-18.9	-19.6	-20.5	-14.2	-9.6	-13.2
cash-flows.row.other-financing-activites	-368.02	-84.4	-59.1	907.2	-44.1	-16.7	-16.2	-12.4	1.6	-12.1	3.6	391.6	16.7	22	690.1	0	0.2	8.4	160.5	138.9	197	90.3	109.7	219.7	71.5	28.6
cash-flows.row.net-cash-used-provided-by-financing-activities	-368.2	-230.1	-462.2	617.6	-168	-141.2	-137.7	-13.2	-24.1	-111.2	-12.5	328.4	-27.7	-86.5	690.1	0	0.2	-37.6	-22.6	-61.6	14.8	-3.3	60.9	99.8	55.9	15.4
cash-flows.row.effect-of-forex-changes-on-cash	817.23	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	552.16	464.7	634.8	288.6	-337	404.7	308.4	235.3	173.8	94.8	89.6	205.8	-14.1	-132.7	203.2	50.1	31.3	-3.7	-38.9	-63	-46.3	22.7	11.4	-24.8	88.8	16.8
cash-flows.row.cash-at-end-of-period	6370.97	2825.2	2360.4	1707.9	1419.2	1756.2	1351.5	1043.1	807.8	634	539.2	449.6	214.6	228.7	349.3	129.1	79	0	3.7	42.6	105.5	151.9	129.1	117.7	142.4	53.7
cash-flows.row.cash-at-beginning-of-period	5818.81	2360.4	1725.6	1419.2	1756.2	1351.5	1043.1	807.8	634	539.2	449.6	243.8	228.7	361.3	146.1	79	47.7	3.7	42.6	105.5	151.9	129.1	117.7	142.4	53.7	36.9
cash-flows.row.operating-cash-flow	698.58	1270	777.7	871.1	694	569.5	497.9	522.1	434.8	365.3	213.4	184	166.9	130.1	200.6	62.1	35.4	235.3	-17.6	17.6	-50.1	28	3.4	-37.1	67.4	14.5
cash-flows.row.capital-expenditure	-197.29	-221.1	-499.8	-218.2	-144.1	-70.1	-43.6	-59.9	-77.4	-137.5	-94.1	-242.1	-101.5	-28.6	-58.5	-12.1	-4.6	-38.2	-5.9	-23.6	-16.6	-7.2	-30.2	-93	-36.1	-13
cash-flows.row.free-cash-flow	501.3	1048.9	277.9	652.9	549.9	499.3	454.3	462.2	357.4	227.7	119.3	-58.1	65.5	101.5	142	50.1	30.8	197.1	-23.6	-6	-66.7	20.8	-26.8	-130.1	31.3	1.4

利润表行

Renhe Pharmacy Co., Ltd. 的收入与上期相比变化了 0.044%。据报告, 000650.SZ 的毛利润为 1886.94。该公司的营业费用为 947.34，与上年相比变化了 1.870%. 折旧和摊销费用为 117.15，与上一会计期间相比变化了 1.189%. 营业费用报告为 947.34，显示1.870% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.081%. 营业收入为 953.26，与上年相比变化了-0.081%. 净利润的变化率为 -0.136%。去年的净收入为574.44.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995	1993
income-statement-row.row.total-revenue	5126.13	5153.2	4935.8	4106.1	4581.2	4403.4	3843.8	3567.1	2523.8	2253.2	1799.4	2087.5	2207.7	1366.8	982.7	876.5	778.7	24.9	267.1	280.4	281.6	220.8	225.1	236.1	236	192.6	136.3	169.5	160.8	132.2	126.3
income-statement-row.row.cost-of-revenue	3179.36	3266.3	3061.4	2456.1	2642.7	2510.6	2347.2	2261.1	1399.2	1222.7	999.5	1265.2	1338.4	659.8	311.6	445.1	481.5	35.4	261.5	281.4	239.6	189.2	234	195.6	190.4	147.5	108.4	130	109	85.5	85.4
income-statement-row.row.gross-profit	1946.77	1886.9	1874.3	1650	1938.5	1892.8	1496.6	1306	1124.6	1030.5	799.9	822.3	869.3	707	671.1	431.3	297.1	-10.4	5.6	-1	42	31.6	-8.9	40.5	45.7	45.2	27.9	39.5	51.8	46.7	40.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	40.41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	86.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	552.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	275.74	269.6	224.8	194.5	219.6	2.4	0.8	9.7	13.3	8.8	14.7	36.3	9.3	1.7	-0.7	2.4	6.8	-48	7.8	18.2	10.6	11.6	17.1	10.5	4	-0.1	0.2	3.6	0.9	1	0.7
income-statement-row.row.operating-expenses	928.5	947.3	929.9	864.3	1124.9	1130.3	942.1	752	577.6	608.6	515.9	515.9	490	420	460.4	334	244.1	-209.3	130.5	72.7	138.8	19.5	14.5	15.7	8.5	6.6	6.6	8	8.6	8.8	6.8
income-statement-row.row.cost-and-expenses	4107.86	4213.6	3991.4	3320.3	3767.5	3640.9	3289.3	3013	1976.8	1831.4	1515.4	1781.1	1828.4	1079.8	772	779.1	725.6	-173.9	392	354.1	378.3	208.7	248.5	211.3	198.9	154.1	115	137.9	8.6	8.8	6.8
income-statement-row.row.interest-income	23.21	24.2	56.7	10.6	37.9	33.2	16.9	1.5	6	3.2	2.6	4.3	3.5	4	1.8	0.4	0.2	5.4	7.3	6.7	5.7	5	8.3	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	0.38	0.4	1	1.4	0.1	0.5	0.5	0.1	5.9	0	0	1.2	1.1	0.7	0.4	1.4	1	26.1	20.1	20.3	19.6	19.6	15.4	10	8.1	4.3	5	12.8	17.2	17.8	14.9
income-statement-row.row.selling-and-marketing-expenses	552.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	0.93	0.3	-2.5	-12.9	-2.3	-7.2	16.1	4.8	25.2	0.5	-7.5	38.7	11.4	2.7	2.1	0	4.9	-69.8	-20.6	-13.9	-14.3	-15	-7.4	-10.2	-8.8	-4.4	-5.2	-10.4	-17.2	-17.8	-14.9
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	275.74	269.6	224.8	194.5	219.6	2.4	0.8	9.7	13.3	8.8	14.7	36.3	9.3	1.7	-0.7	2.4	6.8	-48	7.8	18.2	10.6	11.6	17.1	10.5	4	-0.1	0.2	3.6	0.9	1	0.7
income-statement-row.row.total-operating-expenses	0.93	0.3	-2.5	-12.9	-2.3	-7.2	16.1	4.8	25.2	0.5	-7.5	38.7	11.4	2.7	2.1	0	4.9	-69.8	-20.6	-13.9	-14.3	-15	-7.4	-10.2	-8.8	-4.4	-5.2	-10.4	-17.2	-17.8	-14.9
income-statement-row.row.interest-expense	0.38	0.4	1	1.4	0.1	0.5	0.5	0.1	5.9	0	0	1.2	1.1	0.7	0.4	1.4	1	26.1	20.1	20.3	19.6	19.6	15.4	10	8.1	4.3	5	12.8	17.2	17.8	14.9
income-statement-row.row.depreciation-and-amortization	51.47	173.6	79.3	77.8	106.8	91.8	87.2	80.3	74.1	69	64.2	56.2	29.4	26.8	20.6	8.6	8.3	20.8	22.3	27.4	27.1	26.9	23.5	18.6	12.8	11.5	4.6	11.5	-34.7	-28.9	-25.9
income-statement-row.row.ebitda-caps	1112.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1060.78	953.3	1036.9	860.5	826.2	752.9	569.8	550.2	560.2	415.3	262.3	309	381.4	288.2	213.7	96	51.1	179.6	-122.2	-68.8	-100.5	9	-13.2	25.7	32.9	34.3	16.7	20	26.1	20.1	19.1
income-statement-row.row.income-before-tax	1061.71	953.5	1034.4	847.6	823.9	755.3	570.6	558.9	572.2	422.3	276.5	345.1	390.7	289.6	212.8	97.4	57.9	130.3	-129.9	-69.1	-100.5	8.8	-13.5	25.4	32.6	34.2	16.5	22.4	26.1	20.1	19.1
income-statement-row.row.income-tax-expense	264.64	242	234.5	190	204.6	171.2	129.5	128.1	136.7	98.5	60.5	68.9	84.9	63.9	47.3	27.2	18.7	-43.8	-0.4	6.4	5.3	4.5	-0.7	3.6	4.9	5.9	0.2	7.4	8.6	6.6	6.3
income-statement-row.row.net-income	658.36	574.4	665	580.2	537.8	506.5	380.2	372.4	391.3	300.9	194.2	255.5	300.4	219.5	165.5	70.2	39.2	130.3	-129.9	-69.1	-100.5	8.8	-12.7	21.8	27.7	28.3	16.4	15	17.5	13.5	12.8